“I’m incredibly fortunate to return to NC State where I spent the most formative years of my training and to have the opportunity to join such a talented group of faculty members and industry leaders,”
READ MOREUntil now, veterinarians have had no drug to help cats fight hypertrophic cardiomyopathy, but research led by Dr. Joshua Stern has shown that rapamycin can reverse this devastating disease. The novel therapy is pending conditional approval from the FDA.
READ MOREEsteemed veterinary cardiologist and researcher Dr. Joshua Stern appointed to the TriviumVet Scientific Advisory Board.
READ MOREThe American Veterinary Medical Association (AVMA) today honored Dr. Joshua Stern, associate dean for research and graduate studies and professor of cardiology at North Carolina State University College of Veterinary Medicine, as the winner of the 2024 American Veterinary Medical Foundation (AVMF) Career Achievement in Feline Research Award.
READ MOREJoin us for this exciting discussion as we welcome Dr. Joshua Stern, DVM, PhD, DACVIM (Cardiology) to discuss results of the recently completed RAPACAT trial, evaluating the effects of delayed release rapamycin on left ventricular wall thickness in cats with hypertrophic cardiomyopathy (HCM).
READ MOREOver the last year, research data has indicated some potential hope for anti-hypertrophic drug use in feline hypertrophic cardiomyopathy.
READ MOREOver the last year, research data has indicated some potential hope for anti-hypertrophic drug use in feline hypertrophic cardiomyopathy.
READ MORE